InvestorsHub Logo
Followers 16
Posts 1063
Boards Moderated 0
Alias Born 09/01/2019

Re: Kotato post# 10325

Thursday, 07/02/2020 7:33:07 PM

Thursday, July 02, 2020 7:33:07 PM

Post# of 16706
Maybe another explanation is that Novotech has offices in the Philippines along with many other countries. They kinda owe us for the S Korea delay and are investors in AGN anyway. It makes sense that their connections there be used, to me anyway.
Dr Mark Williams has worked in Eastern Europe and was / is planning Trials there for NASH/AGN, involving CKD and IBD things. Part of the initial reverse merger reason this is now AGN. Those Drugs have obviously taken a back seat right now but there are already connections over there, IMO.
Stuff pr'ed long ago when there was no COVID.
The currently recruiting Aussie / NZ Phase 2 Trials for IPF / CC were set up long ago too, through Novotech. These Trials seem to be relevant to COVID but are totally separate...JMO...GLTA...